Skip to main content
. 2014 Aug 26;2014(8):CD006884. doi: 10.1002/14651858.CD006884.pub3

Comparison 1. Methotrexate versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Proportion of patients maintaining clinical remission 2   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
1.1 Intramuscular methotrexate 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.26 [0.04, 0.48]
1.2 Low dose oral methotrexate 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.23 [‐0.09, 0.56]